Talcum Lawsuit

Talcum Powder Lawsuits

If you or a loved one have been diagnosed with ovarian cancer or fallopian tube cancer and have used Johnson & Johnson’s Baby Powder, Shower to Shower powder, or WalMart’s Equate powder as part of your feminine hygiene routine, you may be entitled to compensation. Free Consultation. No money out of pocket to file your claim.

Get a free case review
We are standing by 24/7, waiting to assist you.




Johnson & Johnson announced Tuesday that it will end North American sales of talc-based baby powder as it battles thousands of lawsuits claiming the product causes cancer.

Read More


In a major win for plaintiffs, a federal judge has ruled that scientific experts can testify before juries on behalf of women who claim talcum powder caused their ovarian cancer.

Read More


CVS Health, Rite Aid, and Walmart are removing all 22-ounce bottles of Johnson & Johnson baby powder from stores due to possible asbestos contamination. The move comes as J&J issued a baby powder recall in response to FDA testing that found asbestos in a bottle purchased online.

The timing could not be worse for J&J as it battles thousands of lawsuits claiming its iconic baby powder contains asbestos and causes cancer. Sanders Phillips Grossman attorney Danielle Mason, who heads the firm’s talcum powder litigation, says the FDA’s finding is a vindication of her work.

Read More


Danielle Ward Mason has joined Sanders Phillips Grossman’s Mass Tort Department and will head the firm’s talcum powder litigation.

Danielle was a member of the talcum powder litigation team that secured nearly $1 billion in verdicts against Johnson & Johnson for failing to warn about ovarian cancer risks. Her work on those cases earned her team a nomination for the 2016 Public Justice Trial Lawyer of the Year Award. She also served as lead attorney for claims involving Invokana and Reglan, and successfully litigated transvaginal mesh (TVM) and Hormone Replacement Therapy (HRT) claims.

“I have been extremely fortunate over my career to help my clients obtain justice against some of the worst corporate actors of our time, and I am thrilled to be able to continue those efforts with SPG,” said Danielle.

Read More


September 1 , 2017 – A Los Angeles jury sided with a California woman last week who blamed her diagnosis of ovarian cancer on decades of Johnson & Johnson’s talcum powder use.  The award of $417 million, consisting of $70 million in compensatory damages and $347 million in punitive damages, makes this the largest verdict against the company in talcum powder lawsuits.

From her hospital bed, Eva Echeverria, 63, said in videotaped testimony that she started using the powder when she was 11 years old and continued to do so even after her diagnosis of ovarian cancer, unaware of the possible link.

“Mrs. Echeverria is dying from this ovarian cancer and she said to me all she wanted to do was to help the other women throughout the whole country who have ovarian cancer for using Johnson & Johnson for 20 and 30 years,” her attorney said.

A spokeswoman for Johnson & Johnson said the company plans to appeal the verdict and “will continue to defend the safety of Johnson’s Baby Powder” because science supports the powder’s safety. They specifically referenced a National Cancer Institute report that states, “the weight of evidence does not support an association between perineal talc exposure and an increased risk of ovarian cancer.”

However, the National Cancer Institute also uses more ambiguous language here where talcum powder is listed under the category of “not clear” as to whether it causes an increased risk of ovarian cancer.

Johnson & Johnson uses another baby powder formula which contains cornstarch rather than talc.  That formula has not been implicated in any ovarian cancer lawsuits.

This week’s verdict follows five other lawsuits against Johnson & Johnson that also alleged the company failed to warn the public of the possible link to ovarian cancer when the talcum powder is used for feminine hygiene purposes for extended periods of time.  Four of those lawsuits ruled in favor of the plaintiff’s, awarding over $307 million to victims.

There are currently almost 5,000 claims against the company alleging J&J knew of the risk of ovarian cancer with its Baby Powder and Shower to Shower products but chose to ignore the studies.

The case is Echeverria et al v. Johnson & Johnson, Los Angeles Superior Court, No. BC628228.


February 10, 2017 – A fourth trial started yesterday in St. Louis against Johnson & Johnson in the high-profile talc litigation.  Plaintiffs’ attorney Ted Meadows referred to the ongoing controversy as simply J&J’s “love of money result[ing] in a manner of all evil.”

Pick up a bottle of baby powder and turn it around and you will not find a warning.  There will be no warning whatsoever regarding cancer,” Meadows said. “Since 1982 at a minimum they’ve known about this directly and done nothing.”


February 9, 2017 – After nearly $200 million in high-profile verdicts against the company, Johnson & Johnson begins trial today in another claim that their talcum powder causes ovarian cancer.

This time, a 56-year old Tennessee woman, Nora Daniels is blaming her diagnosis of ovarian cancer on the product after using it for over 30 years.  She is among thousands of other women nationwide who have filed lawsuits against the company alleging Johnson & Johnson knew of the risk of ovarian cancer but concealed evidence from the public and medical communities.


October 28, 2016 – In a third massive verdict against Johnson & Johnson, a Missouri jury has sided with a woman who claimed her ovarian cancer was caused by Johnson & Johnson’s talcum powder.

Plaintiff Deborah Giannecchini currently lives with Stage 4 ovarian cancer, a reduced life expectancy and has endured devastating treatment complications. “She has literally had her spleen removed, part of her stomach removed, part of her colon removed, all of her ovaries, uterus.”

“She has literally had her spleen removed, part of her stomach removed, part of her colon removed, all of her ovaries, uterus. She has literally had basically the lower half of her body removed,” her attorney Allen Smith Jr. said.  “She said if there would have been a warning on the bottle to not use this on the genital area, she would not have done it and we might not be here.”

Although Giannecchini had initially sought over $285 million in damages, the award of $70 million is still one of the highest to date in an ovarian cancer claim against the company.  Other awards this year have been $72 million and $55 million, also awarded by Missouri state juries.

Smith told of how J&J falsified records and joked about the link between the deadly cancer and baby powder.  He explained in closing arguments that a huge verdict against the “largest corporation in the world” was necessary to “make them stop” and further, that he believed regulatory agencies had been rigged to act in the company’s favor.

Attorney for J&J, David Dukes, argued that there is still no link between ovarian cancer and talcum powder. He said the company relied on the U.S. Food and Drug Administration and Center for Disease Control as trusted medical institutions who looked into the matter and found nothing. “No one knows what causes ovarian cancer,” he said.

“The science is not on their side,” he told jurors. “They know that sometimes we don’t trust federal agencies, particularly during political season.  They know that we all are sympathetic about someone who has had cancer. Why do you think they keep talking about asbestos and tobacco? Because they want to appeal to that dark side of your heart that thinks everybody’s a conspirator and they want to convince you that Johnson & Johnson rigged all those agencies.”

J&J says they intent to appeal the verdict, pointing to two New Jersey cases that we thrown out last month by a judge who cited lack of scientific evidence.

“We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder,” a company spokeswoman said in the statement.


May, 2016 – After eight hours of deliberation, a St. Louis jury has ordered Johnson & Johnson to pay $55 million to a South Dakota woman who had used talcum powder for years, believing it caused her ovarian cancer. Johnson & Johnson still claims they have “provided consumers with a safe choice for cosmetic powder products”, says Carol Goodrich, a spokeswoman for Johnson & Johnson. But the woman’s attorney, Jim Onder, says that there are internal documents showing the company was aware of studies linking the talcum powder to ovarian cancer back to the 1970’s.

“The evidence is real clear that Johnson & Johnson has known about the dangers associated with talcum powder for over 30 years’,” Onder said. “Instead of giving a warning, what they did was targeted the groups most at risk for developing ovarian cancer,” specifically marketing to overweight women, blacks and Hispanics, he said. “What they [J&J] did was targeted the groups most at risk for developing ovarian cancer.”

The company is currently facing over 1,200 pending lawsuits over the issue.


Since the early 1970’s, numerous studies have indicated an increased risk of ovarian cancer in women who use products containing talc around their genital area. Talcum powder has the ability to absorb moisture, reduce friction, and have an astringent effect on human skin, properties that make talc a popular ingredient in cosmetics and hygiene products.

Over the years, numerous studies have emerged that link talc with an increased risk in ovarian cancer:

  • A 1971 study examined the ovaries of numerous women who had been diagnosed with ovarian cancer and found the presence of talc particles in the ovarian tissue of those samples.
  • In 1982, Cancer, a medical journal, published a study that concluded that women who used talcum powder on sanitary napkins in their vaginal area were 33% more likely to develop ovarian cancer.
  • A 2003 study analyzed data collected in a number of previous studies on this topic and concluded that using talc products in the vaginal area resulted in a one-third increase in ovarian cancer risks.
  • A 2013 study published in Cancer Prevention Research suggested that women who use talcum powder in the genital area are at an increased risk of developing ovarian cancer. In that particular study, the data on 2,000 women showed that those who used talc body powder in their genital areas may have a 20 to 30 percent higher risk of developing ovarian cancer than those who do not.


In February 2016, a St. Louis jury found Johnson & Johnson responsible for ovarian cancer that caused the death of Jackie Fox, a woman who had used Johnson’s baby powder for years. It is the first case in which a jury ordered Johnson & Johnson to pay damages for negligence in not warning consumers about the correlation between their talc products and ovarian cancer, despite decades of knowledge of this correlation.
The jury foreman, Krista Smith, cited Johnson & Johnson’s internal company documents as the clear decisive reason for the judgment. Said Smith, “It was really clear they were hiding something. All they had to do was put a label on it.”

“It was really clear they were hiding something. All they had to do was put a label on it.”

In another claim filed in South Dakota against Johnson & Johnson, Deane Berg stated she had used Johnson & Johnson’s Baby Powder and Shower-to-Shower as part of her daily hygiene routine for over 30 years. She claimed the usage of these products caused her to develop ovarian cancer. As proof of this, samples of cancerous tissues taken from Berg were examined by three doctors, all of whom found talc particles within the tissue and concluded the cancer was caused by the talcum powder.

Daniel Cramer, one of the three doctors, testified that in his thirty years of studying the link between talcum powder and ovarian cancer he concluded that talcum powder was a factor in 10,000 ovarian cases annually.

The Jury in Berg’s case decided that Johnson & Johnson was negligent not to warn consumers about the dangers associated with their talcum powder products.

Since this decision, additional lawsuits have been filed against Johnson & Johnson. In April of 2014 Mona Estrada filed a complaint in California alleging that while Johnson & Johnson is aware of the risks related to the usage of their talcum powder products, they have made no efforts to warn consumers about these risks. Estrada’s complaint alleges that the author of a 1982 study linking talcum powder to ovarian cancer advised a doctor employed by Johnson & Johnson to put a warning label about the risk of ovarian cancer on their talcum powder products.


Sanders Phillips Grossman is currently accepting cases from women across the United States and Puerto Rico who have been harmed by the use of talcum powder products. If you or a loved one have been diagnosed with ovarian cancer or fallopian tube cancer and have used Johnson & Johnson Baby Powder, Shower to Shower powder, or WalMart’s Equate powder products containing talc, you may be eligible for compensation.  A successful outcome on your claim could entitle you to damages for medical expenses, wage loss, pain and suffering, loss of enjoyment of life, and loss of consortium.

Unfortunately, we are currently unable to pursue claims for cervical cancer, vaginal cancer, vulvar cancer, endometrial cancer, borderline tumors, ovarian cysts, and non-malignant tumors.


We represent our clients on a contingency fee basis. This means that you pay no attorney fees until we win your claim. If we are unable to successfully resolve your claim, you are not obligated to pay attorneys’ fees.



Sanders Phillips Grossman has been holding pharmaceutical companies responsible for injuring individuals by their defective drugs and devices for over 30 years. Defective drugs are pharmaceuticals with side effects that potentially harm, injure, or kill the patient to the point that they outweigh the drug’s intended benefits. Defective devices, such as faulty prosthetics, implants, pacemakers, or surgical instruments can harm patients when the product is defective in the manufacturing process, design, or marketing strategy.

Pharmaceutical companies are some of the largest, wealthiest, and most influential corporate entities in the world. Sanders Phillips Grossman and its predecessors have recovered over one billion dollars for injured consumers. Our firm’s history in dealing with drug and medical device injury claims has allowed us to take leadership roles in many of the national defective drug and device litigations.

Nationally recognized as a leading plaintiff’s law firm, we handle cases in all 50 states and Puerto Rico.

Read more about our attorneys here.